Development and validation of a COVID-19 vaccination prediction model based on self-reporting results in Chinese older adults from September 2022 to November 2022: A nationwide cross-sectional study.

Dong Liu, Yushi Zhang, Rui Liang, Jieping Lei, Ke Huang, Yaoda Hu, Liwen Fang, Luzhao Feng, Guangliang Shan, Min Wang, Yuanyuan Ding, Qian Gao, Ting Yang
Author Information
  1. Dong Liu: Capital Medical University, Beijing, China.
  2. Yushi Zhang: Peking Union Medical College/Chinese Academy of Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
  3. Rui Liang: National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  4. Jieping Lei: Data and Project Management Unit, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
  5. Ke Huang: National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  6. Yaoda Hu: Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.
  7. Liwen Fang: National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  8. Luzhao Feng: School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  9. Guangliang Shan: Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.
  10. Min Wang: Department of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  11. Yuanyuan Ding: The secretariat, Chinese Association of Geriatric Research, Beijing, China.
  12. Qian Gao: National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
  13. Ting Yang: National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.

Abstract

It was common to see that older adults were reluctant to be vaccinated for coronavirus disease 2019 (COVID-19) in China. There is a lack of practical prediction models to guide COVID-19 vaccination program. A nationwide, self-reported, cross-sectional survey was conducted from September 2022 to November 2022, including people aged 60���years or older. Stratified random sampling was used to divide the dataset into derivation, validation, and test datasets at a ratio of 6:2:2. Least absolute shrinkage and selection operator and multivariable logistic regression were used for variable screening and model construction. Discrimination and calibration were assessed primarily by area under the receiver operating characteristic curve (AUC) and calibration curve. A total of 35057 samples (53.65% males and mean age of 69.64��������7.24���years) were finally selected, which constitutes 93.73% of the valid samples. From 33 potential predictors, 19 variables were screened and included in the multivariable logistic regression model. The mean AUC in the validation dataset was 0.802, with sensitivity, specificity, and accuracy of 0.732, 0.718 and 0.729 respectively, which were similar to the parameters in the test dataset of 0.755, 0.715 and 0.720, respectively, and the mean AUC in the test dataset was 0.815. There were no significant differences between the model predicted values and the actual observed values for calibration in these groups. The prediction model based on self-reported characteristics of older adults was developed that could be useful for predicting the willingness for COVID-19 vaccines, as well as providing recommendations in improving vaccine acceptance.

Keywords

References

  1. Lancet. 2020 Mar 28;395(10229):1054-1062 [PMID: 32171076]
  2. Hum Vaccin Immunother. 2021 Dec 2;17(12):4873-4888 [PMID: 34906026]
  3. BMJ. 2021 Nov 17;375:e068302 [PMID: 34789505]
  4. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Aug;66(8):846-856 [PMID: 37438645]
  5. BMC Geriatr. 2022 Apr 6;22(1):288 [PMID: 35387602]
  6. Vaccines (Basel). 2022 Jul 13;10(7): [PMID: 35891283]
  7. JAMA Intern Med. 2020 Jul 1;180(7):934-943 [PMID: 32167524]
  8. BMC Infect Dis. 2021 Aug 21;21(1):855 [PMID: 34418980]
  9. Vaccines (Basel). 2022 Oct 17;10(10): [PMID: 36298602]
  10. BMJ. 2024 Jan 16;384:e076542 [PMID: 38228339]
  11. Front Public Health. 2021 Aug 02;9:709056 [PMID: 34409011]
  12. BMJ. 2022 Mar 17;376:o707 [PMID: 35302043]
  13. Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1770-1776 [PMID: 35302230]
  14. J Stat Softw. 2010;33(1):1-22 [PMID: 20808728]
  15. Int J Equity Health. 2023 Oct 20;22(1):224 [PMID: 37864164]
  16. Am J Prev Med. 2021 Jan;60(1 Suppl 1):S77-S86 [PMID: 33189502]
  17. Nat Med. 2023 Mar;29(3):623-631 [PMID: 36720270]
  18. Front Public Health. 2022 Dec 15;10:986916 [PMID: 36589991]
  19. Vaccine. 2022 Aug 5;40(33):4806-4815 [PMID: 35788295]
  20. BMC Geriatr. 2023 Dec 9;23(1):828 [PMID: 38066433]
  21. Front Immunol. 2021 Nov 29;12:781161 [PMID: 34912346]
  22. J Med Virol. 2021 Dec;93(12):6535-6543 [PMID: 34255346]
  23. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961 [PMID: 33332359]
  24. Lancet. 2022 Sep 3;400(10354):729-730 [PMID: 36058217]
  25. JAMA. 2024 Jan 23;331(4):283-284 [PMID: 38180773]
  26. J Immunol Methods. 2018 Dec;463:21-26 [PMID: 30114401]
  27. Nat Commun. 2022 Jul 1;13(1):3801 [PMID: 35778396]
  28. Psychol Med. 2022 Oct;52(14):3127-3141 [PMID: 33305716]
  29. BMJ. 2021 May 13;373:n1088 [PMID: 33985964]
  30. J Clin Immunol. 2021 Jan;41(1):194-204 [PMID: 33403466]
  31. Lancet. 2022 Dec 3;400(10367):1967-2006 [PMID: 36423650]
  32. BMJ. 2024 Jan 16;384:q82 [PMID: 38228338]

MeSH Term

Humans
Cross-Sectional Studies
Male
Aged
Female
COVID-19
COVID-19 Vaccines
Self Report
China
Middle Aged
Vaccination
SARS-CoV-2
Logistic Models
Aged, 80 and over
ROC Curve
East Asian People

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.00modelCOVID-19olderpredictiondatasetadultscross-sectional2022validationtestcalibrationAUCmeanvaccinevaccinationnationwideself-reportedSeptemberNovemberusedmultivariablelogisticregressioncurvesamplesrespectivelyvaluesbasedstudycommonseereluctantvaccinatedcoronavirusdisease2019Chinalackpracticalmodelsguideprogramsurveyconductedincludingpeopleaged60���yearsStratifiedrandomsamplingdividederivationdatasetsratio6:2:2LeastabsoluteshrinkageselectionoperatorvariablescreeningconstructionDiscriminationassessedprimarilyareareceiveroperatingcharacteristictotal350575365%malesage6964��������724���yearsfinallyselectedconstitutes9373%valid33potentialpredictors19variablesscreenedincluded802sensitivityspecificityaccuracy732718729similarparameters755715720815significantdifferencespredictedactualobservedgroupscharacteristicsdevelopedusefulpredictingwillingnessvaccineswellprovidingrecommendationsimprovingacceptanceDevelopmentself-reportingresultsChinese2022:hesitancy

Similar Articles

Cited By